Eli Lilly threatens to end 340B discounts for about 50 covered entities
Issue
On June 1, Eli Lilly warned roughly 50 covered entities that they have five days to submit full claims data or lose 340B price breaks, STAT reported. STAT says more than 2,300 entities have complied, while up to 1,000 larger systems have refused.
The first round targets hospital systems, but the policy also covers FQHCs that dispense Lilly drugs.
Sources for this story
STAT NewsPart of
- 340B drug pricing
Manufacturer restrictions and data demands
Sources for your board packet
This story's source plus 4 related stories and their sources, ready to print for your team or board.
Free. Unlocking the packet subscribes you to Intel Brief. You'll also get a short welcome series and the occasional product update. You'll be subscribed right away, with no confirmation email. Unsubscribe with one click in any issue. If you unsubscribed before, we won't re-add you. We never sell your email. You can open each source above without an email.
More in Risk & Compliance
Nov 9
CMS gives drugmakers no safe harbor when 340B entities withhold claim data
Nov 5
Missouri drops and Colorado delays the Medicaid work requirement hardship exception
Nov 4
CMS makes Part D 340B claims reporting mandatory starting in 2027
Nov 3
HHS finalizes Section 504 rule on gender dysphoria and disability
FQHC Talent. (2026, June 1). Eli Lilly threatens to end 340B discounts for about 50 covered entities. Source: STAT News. Retrieved November 11, 2026, from https://www.fqhctalent.com/intel/lilly-340b-five-day-data-ultimatum-june-1-2026